PNL has received two contracts with the Army, totaling nearly $1 million. An $879,000 Phase II Small Business Innovation Research grant will help Phoenix develop and build a high flux neutron generator to detect improvised explosive devices.Read more +
Phoenix Nuclear Labs announced today that it has been awarded two contracts with the US Army for new applications of its platform technology. Phoenix Nuclear Labs was awarded an $879,000 SBIR Phase II Enhancement grant to design and build a high flux neutron generator for mobile detection of improvised explosive devices (IED’s).Read more +
While molybdenum-99 might sound like a term carefully crafted in the musty basement office of an aspiring Star Trek scriptwriter, it’s a real, and vitally important, isotope that’s crucial to many modern diagnostic procedures.Read more +
Ahead of this week’s Society of Nuclear Medicine meeting and the July gathering of the Organization for Economic Cooperation and Development, the United States is announcing steps to ensure the reliable supply of medical isotopes while minimizing the use of highly enriched uranium (HEU) for civilian purposes.Read more +
Phoenix Nuclear Labs announced today it has joined the EDGE® Innovation Network, a collaborative, open-environment initiative enabling industry and academia, with government input, to work together to enhance the delivery cycle of new technologies and innovative capabilities to warfighters and first responders.
“We look forward to working with the broad range of companies within the EDGE network,” said Ross Radel, president of Phoenix Nuclear Labs.
SHINE Medical Technologies has been getting a lot of attention lately for a $20 million agreement with the DOE aimed at making a critical but scarce isotope used to screen for heart disease and cancer.Read more +
Phoenix Nuclear Labs has successfully completed a $590,500 round of equity fundraising to advance its particle accelerator technology. The investment round was led by the Madison-based angel investment group Wisconsin Investment Partners and Wisconsin native Fred Mancheski, former chairman and CEO of Echlin.Read more +
The National Nuclear Security Administration’s (NNSA) Global Threat Reduction Initiative (GTRI) announced today the signing of a cooperative agreement with the Morgridge Institute for Research (Morgridge) to further the development of accelerator-based technology to produce molybdenum-99 (Mo-99) in the United States without the use of proliferation-sensitive highly enriched uranium (HEU).Read more +